Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy K Wehn

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Developmental Biology|September 14, 2010
Tbx18 and Tbx15 null-like phenotypes in mouse embryos expressing Tbx6 in somitic and lateral plate mesodermAmy K Wehn, Deborah L Chapman
Genesis (New York, N.Y. : 2000)|March 21, 2009
Generation of transgenic mice expressing Cre recombinase under the control of the Dll1 mesoderm enhancer elementAmy K Wehn, Phillip H Gallo, Deborah L Chapman
Biology Open|August 29, 2020
Functionally distinct roles for T and Tbx6 during mouse developmentAmy K Wehn, Deborah R Farkas, Carly E Sedlock, et al.
Gynecologic Oncology|June 25, 2026
Technical evaluation of commercially available homologous recombination deficiency assays using MyChoice CDx as reference in ovarian cancerAlexander Yarunin, Ping Qiu, Xiaodun Li, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2009
In vitro neural differentiation of human embryonic stem cells using a low-density mouse embryonic fibroblast feeder protocolJohn A Ozolek, Esther P Jane, James E Esplen, et al.
Cytotherapy|December 11, 2017
Corrigendum to "A consensus introduction to serum replacements and serum-free media for cellular therapies" [Cytotherapy 19 (2017) 155-169]Ohad Karnieli, Oryan Makler Friedner, Julie G Allickson, et al.
Cytotherapy|December 27, 2016
A consensus introduction to serum replacements and serum-free media for cellular therapiesOhad Karnieli, Oryan Makler Friedner, Julie G Allickson, et al.
NPJ Precision Oncology|September 14, 2024
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to PembrolizumabDouglas I Lin, Julia C F Quintanilha, Natalie Danziger, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Developmental Biology|September 14, 2010
Tbx18 and Tbx15 null-like phenotypes in mouse embryos expressing Tbx6 in somitic and lateral plate mesodermAmy K Wehn, Deborah L Chapman
Genesis (New York, N.Y. : 2000)|March 21, 2009
Generation of transgenic mice expressing Cre recombinase under the control of the Dll1 mesoderm enhancer elementAmy K Wehn, Phillip H Gallo, Deborah L Chapman
Biology Open|August 29, 2020
Functionally distinct roles for T and Tbx6 during mouse developmentAmy K Wehn, Deborah R Farkas, Carly E Sedlock, et al.
Gynecologic Oncology|June 25, 2026
Technical evaluation of commercially available homologous recombination deficiency assays using MyChoice CDx as reference in ovarian cancerAlexander Yarunin, Ping Qiu, Xiaodun Li, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2009
In vitro neural differentiation of human embryonic stem cells using a low-density mouse embryonic fibroblast feeder protocolJohn A Ozolek, Esther P Jane, James E Esplen, et al.
Cytotherapy|December 11, 2017
Corrigendum to "A consensus introduction to serum replacements and serum-free media for cellular therapies" [Cytotherapy 19 (2017) 155-169]Ohad Karnieli, Oryan Makler Friedner, Julie G Allickson, et al.
Cytotherapy|December 27, 2016
A consensus introduction to serum replacements and serum-free media for cellular therapiesOhad Karnieli, Oryan Makler Friedner, Julie G Allickson, et al.
NPJ Precision Oncology|September 14, 2024
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to PembrolizumabDouglas I Lin, Julia C F Quintanilha, Natalie Danziger, et al.
Pageof 1